Non-invasive radionuclide imaging of trace metal trafficking in health and disease:“PET metallomics”
Several specific metallic elements must be present in the human body to maintain health
and function. Maintaining the correct quantity (from trace to bulk) and location at the cell and …
and function. Maintaining the correct quantity (from trace to bulk) and location at the cell and …
Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran
During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging
In order to develop a possible CXC chemokine receptor type 4 (CXCR4) imaging agent for
oncological scintigraphy,[62 Zn] labeled 1, 1′-[1, 4-phenylenebis (methylene)] bis-1, 4, 8 …
oncological scintigraphy,[62 Zn] labeled 1, 1′-[1, 4-phenylenebis (methylene)] bis-1, 4, 8 …
[PDF][PDF] Preparation and quality control of scandium-46 bleomycin as a possible therapeutic agent
L Moghaddam-Banaem, AR Jalilian… - Iranian Journal of …, 2012 - researchgate.net
Introduction: Due to interesting therapeutic properties of 46Sc and antineoblastic antibiotic,
bleomycin (BLM), 46Sc-bleomycin (46Sc-BLM) was developed as a possible therapeutic …
bleomycin (BLM), 46Sc-bleomycin (46Sc-BLM) was developed as a possible therapeutic …
Preparation and quality control of lutetium-177 bleomycin as a possible therapeutic agent
H Yousefnia, AR Jalilian, S Zolghadri… - Nukleonika, 2010 - infona.pl
Due to interesting therapeutic properties of 177Lu and antineoblastic antibiotic, bleomycin
(BLM), 177Lu-bleomycin (177Lu-BLM) was developed as a possible therapeutic compound …
(BLM), 177Lu-bleomycin (177Lu-BLM) was developed as a possible therapeutic compound …
Synthesis, characterization and in vivo evaluation of [62Zn]–benzo-δ-sultam complex as a possible pet imaging agent
Objective The development of a new tracer based on the cyclic sulfonamides (sultams) was
investigated. Methods 3-(Methoxy-phenyl-methyl)-1, 6-dimethyl-1H benzo [c][1, 2] thiazine 2 …
investigated. Methods 3-(Methoxy-phenyl-methyl)-1, 6-dimethyl-1H benzo [c][1, 2] thiazine 2 …
Biological studies of samarium-153 bleomycin complex in human breast cancer murine xenografts for therapeutic applications
A Bahrami-Samani, M Ghannadi-Maragheh… - rca-Radiochimica …, 2010 - degruyter.com
In this work, a potential therapeutic DNA targeting agent, 153Sm-bleomycin complex
(153Sm-BLM), was developed and the tumor accumulation studies were performed using …
(153Sm-BLM), was developed and the tumor accumulation studies were performed using …
Development of 166 Ho bleomycin as a possible therapeutic complex
S Zolghadri, A Jalilian, H Yousefnia… - … of radioanalytical and …, 2010 - akjournals.com
Due to interesting therapeutic properties of 166 Ho and the antineoblastic antibiotic,
bleomycin (BLM), 166 Ho-bleomycin (166 Ho-BLM) was developed as a possible …
bleomycin (BLM), 166 Ho-bleomycin (166 Ho-BLM) was developed as a possible …
Preparation and biological evaluation of [61Cu] bleomycin complex as a possible PET radiopharmaceutical in normal and fibrosarcoma-bearing animals
[61Cu] bleomycin ([61Cu] BLM) was prepared using [61Cu] CuCl2 produced via natZn (p, x)
61Cu.[61Cu] BLM was prepared under optimized conditions (room temperature, 45 min, 0.1 …
61Cu.[61Cu] BLM was prepared under optimized conditions (room temperature, 45 min, 0.1 …
Development of [62Zn/62Cu]-DOTA-rituximab as a possible novel in vivo PET generator for anti-CD20 antigen imaging
In this study, zinc-62 was prepared at radiopharmaceutical grade (for 62Zn/62Cu generator
production) using natCu (p, xn) reaction with the production yield of 5.9 mCi/μ Ah at 30 MeV …
production) using natCu (p, xn) reaction with the production yield of 5.9 mCi/μ Ah at 30 MeV …